Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European UnionOSAKA, ...

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...

Seasoned Leadership Joins to Support Growth and R&D and Meet Demand for Continuous Care Solution in Retinal DiseaseRALEIGH, N ...

TEAM Technologies (“TEAM Tech”), a leading end-to-end outsourced manufacturer of mission-critical medical devices, announces ...

SAN FRANCISCO, CA AND BRENTWOOD, TN / ACCESS Newswire / September 17, 2025 / Ardent Health, a leading provider of healthcare ...

Parker Moffa, Chief Operating Officer announced today the official launch of Freight Linq, a modern freight brokerage firm ...

Keensight Capital ("Keensight"), one of the leading private equity managers dedicated to pan-European Growth Buyout [1] ...

NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Visionary Holdings Inc. (NASDAQ:GV) ("GV" or the "Company"), a ...

Medincell (Paris:MEDCL):Data from the completed phase 3 SOLARIS trial to be presented at the 2025 Psych Congress Annual ...

Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma ...

Almirall’s scientific presence at the 34th EADV congress reflects its broad portfolio of dermatological treatments and ...

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life ...